September 13, 2022
Life Sciences
  • The Food and Drug Administration (FDA) will consider Perrigo Co. PLC’s application to make its daily birth control pill available over the counter during a joint meeting on November 18. If the FDA’s Nonprescription Drugs Advisory Committee and Obstetrics, Reproductive, and Urologic Drugs Advisory Committee sign off on the plan, Perrigo’s pill would be the first nonprescription daily birth control offering in the United States. (Articles here, here, and here)